Amir is a Clinical Scientist, Strategic Advisor, and Global Thought Leader at the forefront of Digital Health and Modern Medicine. Amir is on a mission to bring together the brightest minds from far-ranging disciplines to create a community of like-minded people who keep pushing the boundaries of tech innovation and AI solutions for better patient care. He sits on the advisory board of multiple medtech startups and holds strategic consulting roles with leading pharmaceutical companies. In the startup world, Amir works with promising companies on developing clinically-validated products, helps them break into the pharma and healthcare arenas, and sets them up for sustainable growth and commercial success. In the biotech industry, he works with drug companies on developing smart digital solutions across the pipeline, helping them drive impact and adoption at scale. During his time at Pfizer, Amir led the development of wearable tech and remote monitoring solutions for gene therapy trials, primarily in rare diseases. Prior to pharma, Amir was a PI on numerous clinical trials as a Neurology Faculty and Professor of Pediatrics at Harvard Medical School. Amir leads Redenlab’s digital health & strategy, driving innovation in new markets and disease groups.